This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Effect of Clinical Selection on the Observed Incidence of Malignancy

JOSEPH E. SOKAL, M.D.

AMA Arch Intern Med. 1957;99(1):60-69.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There has been a great deal of controversy in recent years over the management of nontoxic nodular goiter. Many authorities have insisted that all such goiters should be extirpated because of the risk that they are, or might become, malignant.^1-4 Some of them have claimed that as many as 15% of nontoxic nodular goiters are malignant.^3,4 Others have pointed out that thyroid cancer is a rare disease, while nodular goiter is fairly common, and that figures such as the above, which are based on highly selected surgical statistics, are not applicable to the population as a whole.^5-8 The true prevalence of malignancy in nontoxic nodular goiter has been estimated by these authors to be considerably less than 1%. Several authorities have concluded that routine removal of all nontoxic nodular goiters is not indicated, and would in fact cause a surgical morbidity and mortality which would outweigh the . . . [Full Text PDF of this Article]

Author Affiliations
Buffalo

From the Department of Internal Medicine, Yale University School of Medicine, and the Division of Medicine, Roswell Park Memorial Institute.

Footnotes
Received for publication Jan. 3, 1956.

Supported in part by an institutional research grant from the American Cancer Society.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?